Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
Saved in:
| Title: | Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition. |
|---|---|
| Authors: | Dos Santos ES; Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil.; Service de Génétique, Institut Curie, Paris, France.; A.C.Camargo Cancer Center, São Paulo, Brazil., Caputo SM; Service de Génétique, Institut Curie, Paris, France., Castera L; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France., Gendrot M; Service de Génétique, Institut Curie, Paris, France., Briaux A; Service de Génétique, Institut Curie, Paris, France., Breault M; Service de Génétique, Institut Curie, Paris, France., Krieger S; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France., Rogan PK; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada., Mucaki EJ; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada., Burke LJ; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia., Bièche I; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France., Houdayer C; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France., Vaur D; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France., Stoppa-Lyonnet D; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France., Brown MA; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia., Lallemand F; Service de Génétique, Institut Curie, Paris, France. francois.lallemand@curie.fr., Rouleau E; Gustave Roussy, Villejuif, France. Etienne.rouleau@gustaveroussy.fr. |
| Corporate Authors: | ENIGMA consortium |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Apr; Vol. 168 (2), pp. 311-325. Date of Electronic Publication: 2017 Dec 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29236234 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dos+Santos+ES%22">Dos Santos ES</searchLink>; Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil.; Service de Génétique, Institut Curie, Paris, France.; A.C.Camargo Cancer Center, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Caputo+SM%22">Caputo SM</searchLink>; Service de Génétique, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Castera+L%22">Castera L</searchLink>; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France.<br /><searchLink fieldCode="AU" term="%22Gendrot+M%22">Gendrot M</searchLink>; Service de Génétique, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Briaux+A%22">Briaux A</searchLink>; Service de Génétique, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Breault+M%22">Breault M</searchLink>; Service de Génétique, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Krieger+S%22">Krieger S</searchLink>; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France.<br /><searchLink fieldCode="AU" term="%22Rogan+PK%22">Rogan PK</searchLink>; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada.<br /><searchLink fieldCode="AU" term="%22Mucaki+EJ%22">Mucaki EJ</searchLink>; Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada.<br /><searchLink fieldCode="AU" term="%22Burke+LJ%22">Burke LJ</searchLink>; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Bièche+I%22">Bièche I</searchLink>; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France.<br /><searchLink fieldCode="AU" term="%22Houdayer+C%22">Houdayer C</searchLink>; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vaur+D%22">Vaur D</searchLink>; Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France.<br /><searchLink fieldCode="AU" term="%22Stoppa-Lyonnet+D%22">Stoppa-Lyonnet D</searchLink>; Service de Génétique, Institut Curie, Paris, France.; Université Paris Descartes, Paris, France.<br /><searchLink fieldCode="AU" term="%22Brown+MA%22">Brown MA</searchLink>; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Lallemand+F%22">Lallemand F</searchLink>; Service de Génétique, Institut Curie, Paris, France. francois.lallemand@curie.fr.<br /><searchLink fieldCode="AU" term="%22Rouleau+E%22">Rouleau E</searchLink>; Gustave Roussy, Villejuif, France. Etienne.rouleau@gustaveroussy.fr. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ENIGMA+consortium%22">ENIGMA consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2018 Apr; Vol. 168 (2), pp. 311-325. <i>Date of Electronic Publication: </i>2017 Dec 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29236234 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10549-017-4602-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 311 Titles: – TitleFull: Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dos Santos ES – PersonEntity: Name: NameFull: Caputo SM – PersonEntity: Name: NameFull: Castera L – PersonEntity: Name: NameFull: Gendrot M – PersonEntity: Name: NameFull: Briaux A – PersonEntity: Name: NameFull: Breault M – PersonEntity: Name: NameFull: Krieger S – PersonEntity: Name: NameFull: Rogan PK – PersonEntity: Name: NameFull: Mucaki EJ – PersonEntity: Name: NameFull: Burke LJ – PersonEntity: Name: NameFull: Bièche I – PersonEntity: Name: NameFull: Houdayer C – PersonEntity: Name: NameFull: Vaur D – PersonEntity: Name: NameFull: Stoppa-Lyonnet D – PersonEntity: Name: NameFull: Brown MA – PersonEntity: Name: NameFull: Lallemand F – PersonEntity: Name: NameFull: Rouleau E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2018 Apr Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1573-7217 Numbering: – Type: volume Value: 168 – Type: issue Value: 2 Titles: – TitleFull: Breast cancer research and treatment Type: main |
| ResultId | 1 |